Join
Live feed
·
PRReleasevia Quantisnow
Century Therapeutics Inc. logo

New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026

ByQuantisnow·Wall Street's wire, on your screen.
IPSC· Century Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IPSC (Century Therapeutics Inc.) and more on Quantisnow.